Diana Cardona to Prognosis
This is a "connection" page, showing publications Diana Cardona has written about Prognosis.
Connection Strength
0.099
-
Cullen MM, Lazarides AL, Pittman PD, Flamant EM, Stoeber KL, Stoeber K, Visguass JD, Brigman BE, Riedel RF, Cardona DM, Somarelli JA, Eward WC. Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma. BMC Cancer. 2024 Oct 17; 24(1):1288.
Score: 0.040
-
Lazarides AL, Abar B, Leckey B, Martin JT, Kliassov EG, Brigman BE, Eward WC, Cardona DM, Visgauss JD. Tumor necrosis is an underappreciated histopathologic factor in the grading of chondrosarcoma. BMC Cancer. 2023 Jun 23; 23(1):579.
Score: 0.037
-
Nussbaum DP, Rushing CN, Lane WO, Cardona DM, Kirsch DG, Peterson BL, Blazer DG. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016 Jul; 17(7):966-975.
Score: 0.022